ArticleFrontiers in pharmacology2025
Wound healing and photodynamic potential of
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic and infected wounds represent a persistent global health burden. Medicinal plants offer a promising source of wound-healing agents due to their multitarget activities, long history of traditional use, and accessibility. Methods: We evaluated the effects of methanol extracts of ACV (ACVM) on cell proliferation, migration and antioxidative capacity in human keratinocytes (HaCaT), and anti-inflammatory activity in RAW 264.7 cells. We also explored its combination with visible light phototherapy. Results: Chemical profiling via HPTLC analysis, UV/Vis spectrophotometry and HPLC analysis, together confirmed that ACVM contained more metabolites than other extracts, yielding five visible-light absorption peaks and identifying rutin and chlorogenic acid as major metabolites. At ≤100 μg/mL, ACVM was non-toxic to HaCaT cells in the absence of visible light. However, phototoxicity was evident at 200 μg/mL. ACVM (50 μg/mL) significantly promoted HaCaT migration, with a further enhancement upon exposure to light. ACVM also suppressed H Discussion: These findings suggest that ACVM, particularly in combination with light-assisted therapy, shows promise for accelerating wound healing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.